PMC:7408073 / 42859-43181 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T270","span":{"begin":84,"end":90},"obj":"Body_part"}],"attributes":[{"id":"A270","pred":"fma_id","subj":"T270","obj":"http://purl.org/sig/ont/fma/fma7203"}],"text":"In line with these hypotheses, both asthmatic/allergic disease patients and chronic kidney disease patients without a history of cardiovascular disease, which are protected from developing COVID-19, showed a significant decrease in both circulating zinc levels and ACE2 activity as compared to normal values [96,97,98,99]."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T100","span":{"begin":84,"end":90},"obj":"Body_part"}],"attributes":[{"id":"A100","pred":"uberon_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"}],"text":"In line with these hypotheses, both asthmatic/allergic disease patients and chronic kidney disease patients without a history of cardiovascular disease, which are protected from developing COVID-19, showed a significant decrease in both circulating zinc levels and ACE2 activity as compared to normal values [96,97,98,99]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1588","span":{"begin":265,"end":269},"obj":"Gene"},{"id":"1608","span":{"begin":63,"end":71},"obj":"Species"},{"id":"1609","span":{"begin":99,"end":107},"obj":"Species"},{"id":"1642","span":{"begin":36,"end":62},"obj":"Disease"},{"id":"1643","span":{"begin":76,"end":98},"obj":"Disease"},{"id":"1644","span":{"begin":129,"end":151},"obj":"Disease"},{"id":"1645","span":{"begin":189,"end":197},"obj":"Disease"}],"attributes":[{"id":"A1588","pred":"tao:has_database_id","subj":"1588","obj":"Gene:59272"},{"id":"A1608","pred":"tao:has_database_id","subj":"1608","obj":"Tax:9606"},{"id":"A1609","pred":"tao:has_database_id","subj":"1609","obj":"Tax:9606"},{"id":"A1642","pred":"tao:has_database_id","subj":"1642","obj":"MESH:D004342"},{"id":"A1643","pred":"tao:has_database_id","subj":"1643","obj":"MESH:D051436"},{"id":"A1644","pred":"tao:has_database_id","subj":"1644","obj":"MESH:D002318"},{"id":"A1645","pred":"tao:has_database_id","subj":"1645","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In line with these hypotheses, both asthmatic/allergic disease patients and chronic kidney disease patients without a history of cardiovascular disease, which are protected from developing COVID-19, showed a significant decrease in both circulating zinc levels and ACE2 activity as compared to normal values [96,97,98,99]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T250","span":{"begin":46,"end":62},"obj":"Disease"},{"id":"T251","span":{"begin":46,"end":54},"obj":"Disease"},{"id":"T252","span":{"begin":76,"end":98},"obj":"Disease"},{"id":"T253","span":{"begin":84,"end":98},"obj":"Disease"},{"id":"T255","span":{"begin":129,"end":151},"obj":"Disease"},{"id":"T256","span":{"begin":189,"end":197},"obj":"Disease"}],"attributes":[{"id":"A250","pred":"mondo_id","subj":"T250","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"},{"id":"A251","pred":"mondo_id","subj":"T251","obj":"http://purl.obolibrary.org/obo/MONDO_0004980"},{"id":"A252","pred":"mondo_id","subj":"T252","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A253","pred":"mondo_id","subj":"T253","obj":"http://purl.obolibrary.org/obo/MONDO_0001343"},{"id":"A254","pred":"mondo_id","subj":"T253","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"},{"id":"A255","pred":"mondo_id","subj":"T255","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"},{"id":"A256","pred":"mondo_id","subj":"T256","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"In line with these hypotheses, both asthmatic/allergic disease patients and chronic kidney disease patients without a history of cardiovascular disease, which are protected from developing COVID-19, showed a significant decrease in both circulating zinc levels and ACE2 activity as compared to normal values [96,97,98,99]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T526","span":{"begin":84,"end":90},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T527","span":{"begin":84,"end":90},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T528","span":{"begin":84,"end":90},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T529","span":{"begin":116,"end":117},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T530","span":{"begin":206,"end":207},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T531","span":{"begin":270,"end":278},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"In line with these hypotheses, both asthmatic/allergic disease patients and chronic kidney disease patients without a history of cardiovascular disease, which are protected from developing COVID-19, showed a significant decrease in both circulating zinc levels and ACE2 activity as compared to normal values [96,97,98,99]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T444","span":{"begin":249,"end":253},"obj":"Chemical"}],"attributes":[{"id":"A444","pred":"chebi_id","subj":"T444","obj":"http://purl.obolibrary.org/obo/CHEBI_27363"},{"id":"A445","pred":"chebi_id","subj":"T444","obj":"http://purl.obolibrary.org/obo/CHEBI_30185"}],"text":"In line with these hypotheses, both asthmatic/allergic disease patients and chronic kidney disease patients without a history of cardiovascular disease, which are protected from developing COVID-19, showed a significant decrease in both circulating zinc levels and ACE2 activity as compared to normal values [96,97,98,99]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T207","span":{"begin":0,"end":322},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In line with these hypotheses, both asthmatic/allergic disease patients and chronic kidney disease patients without a history of cardiovascular disease, which are protected from developing COVID-19, showed a significant decrease in both circulating zinc levels and ACE2 activity as compared to normal values [96,97,98,99]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T67","span":{"begin":76,"end":98},"obj":"Phenotype"},{"id":"T68","span":{"begin":129,"end":151},"obj":"Phenotype"}],"attributes":[{"id":"A67","pred":"hp_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/HP_0012622"},{"id":"A68","pred":"hp_id","subj":"T68","obj":"http://purl.obolibrary.org/obo/HP_0001626"}],"text":"In line with these hypotheses, both asthmatic/allergic disease patients and chronic kidney disease patients without a history of cardiovascular disease, which are protected from developing COVID-19, showed a significant decrease in both circulating zinc levels and ACE2 activity as compared to normal values [96,97,98,99]."}

{"project":"2_test","denotations":[{"id":"32708755-25813276-20678798","span":{"begin":309,"end":311},"obj":"25813276"}],"text":"In line with these hypotheses, both asthmatic/allergic disease patients and chronic kidney disease patients without a history of cardiovascular disease, which are protected from developing COVID-19, showed a significant decrease in both circulating zinc levels and ACE2 activity as compared to normal values [96,97,98,99]."}